Reshaping Rx: Navigating 2025 Drug Pricing Policies Webinar on June 26 at 12:00 PM EDT
Join us for a free webinar as experts break down the latest federal and state policy developments shaping the pharmaceutical landscape in 2025. We’ll explore what these shifts mean for manufacturers, payers, providers, and patients.
New Findings Highlight Key Role of Clinician Communication in Lymphoma, CLL Care: Lorna Warwick
Health Equity & Access Weekly Roundup: June 23, 2025
Culture Key to Data Collection of Sexual Orientation and Gender Identity in Cancer Care
5 Health Crises America Urgently Needs to Address for Black Communities
Democratic Doctors Caucus Reaffirms EMTALA Amid Trump's CMS Policy Reversal on Abortion Care
Addressing Barriers to Hispanic Men's Engagement in Diabetes Prevention
Scaling Early Palliative Care in Value-Based Community Oncology: A Technology-Enabled Approach
10 Years of Coverage Gains Threatened by Proposed Federal Policy Changes, Report Finds
Hospital Management Involvement Impacts Health-Related Social Needs Program Adoption
Managed Care Cast News Roundup: June 17, 2025
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
The Role of MRD Status in Post-ASCT Treatment Decisions and Clinical Integration
The Future of BTK Inhibitor Therapies in CLL and MCL
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Closing Perspectives
New Findings Highlight Key Role of Clinician Communication in Lymphoma, CLL Care: Lorna Warwick
Strategies for Managing Costs of Long-Term BTK Inhibitor Therapy
Payer Policies and Access Strategies
NCCN Guideline Updates Help Oncologists Navigate ctDNA Use: Eric Lander, MD
How the Win Ratio Benefits Patients With COPD: Sanjay Ramakrishnan, MD
Overview of Spinal Muscular Atrophy
New Findings Highlight Key Role of Clinician Communication in Lymphoma, CLL Care: Lorna Warwick
How the Win Ratio Benefits Patients With COPD: Sanjay Ramakrishnan, MD
CARTITUDE-4 Data Solidify Cilta-cel’s Role in RRMM: Surbhi Sidana, MD, MBBS
Teledermatology Shows Promise to Reduce Disparities in Skin Cancer Screening
Population Health Reimagined Through Integrated Care
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
Optimizing Advanced Cancer Therapies and Addressing Logistical, Financial Challenges
Value-Based Care Calls for Putting Novel Therapies Closer to Patients
Will Subcutaneous PD-1/PD-L1 Inhibitors Be a Game Changer?
Risk Factors for Financial Toxicity in Health Care
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model
Challenges Faced by Medicaid Managed Care Coordinators Working With Members With Substance Use Disorder
Affordable Care Act Enrollment in Texas After Rating Area Adjustments
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence
The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies
Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)
